AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Sopharma AD

Transaction in Own Shares • Sep 25, 2018

2543_rns_2018-09-25_2761c354-12b9-4e21-b5dd-bc5654f2d8ed.pdf

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

ACQUISITION OF OWN SHARES

Current report No 110/2018 Dated 25 September 2018

Sopharma AD notifies that on 21 September 2018 the Company bought 3 375 own shares representing 0.0025% of the share capital of the Company, at a total value of 13 770.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.08 BGN.

The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.

As a result of the merger of Unipharm AD into Sopharma AD 70 623 shares of the treasury shares of the Company were transferred to the shareholders of Unipharm AD. The total number of treasury shares after this transfer is 9 110 752, representing 6.76% of the share capital of the Company.

Signatures of individuals authorized to represent the Company

Ognian Donev